
Trinity Innovation Fund
Asia, Beijing, China, Beijing'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Trinity Innovation Fund is a fund management company that mainly focuses its investments on pharmaceutical innovation projects.
Investor Profile
Trinity Innovation Fund has backed more than 4 startups, with 2 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series C, Seed rounds (top funding stages).
- Majority of deals are located in United States, China.
- Strong thematic focus on Biotechnology, Biopharma, Pharmaceutical.
Stage Focus
- Series A (50%)
- Series C (25%)
- Seed (25%)
Country Focus
- United States (50%)
- China (50%)
Industry Focus
- Biotechnology
- Biopharma
- Pharmaceutical
- Neuroscience
- Health Care
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.